← Back to Clinical Trials
Recruiting NCT05464186

NCT05464186 Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05464186
Status Recruiting
Phase
Sponsor Boston Children's Hospital
Condition Obesity
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2022-12-28
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Whole milkNonfat milk

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2022-12-28 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate the effects of whole vs. nonfat milk consumption on body composition, cardiometabolic disease risk factors, and dietary quality.

Eligibility Criteria

Inclusion Criteria: * Aged 9 to 12 years * BMI ≥75th percentile for sex and age * Residence in the Greater Boston catchment area Exclusion Criteria: * Aversion to nonfat or whole milk * Physician diagnosis of major medical illness, eating disorder, or milk allergy (lactose intolerance not exclusionary as lactase treated milk can be provided) * Plans to move away from the Greater Boston catchment area during the study period * Plans to be away from home for ≥5 weeks during the study period (e.g., extended summer vacation) * Change in body weight exceeding 10% during prior year * Recent adherence to a special diet * Chronic use of any medication or dietary supplement that could affect study outcomes * Another member of the family (first degree relative) or household participating in the study

Contact & Investigator

Central Contact

Donna L Lesperance, MA, MPH

✉ Donna.Lesperance@childrens.harvard.edu

📞 617-919-7305

Principal Investigator

Cara B Ebbeling, PhD

PRINCIPAL INVESTIGATOR

Boston Children's Hospital

Frequently Asked Questions

Who can join the NCT05464186 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05464186 currently recruiting?

Yes, NCT05464186 is actively recruiting participants. Contact the research team at Donna.Lesperance@childrens.harvard.edu for enrollment information.

Where is the NCT05464186 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT05464186 clinical trial?

NCT05464186 is sponsored by Boston Children's Hospital. The principal investigator is Cara B Ebbeling, PhD at Boston Children's Hospital. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology